NervGen Pharma Corp. (NGENF)
OTCMKTS · Delayed Price · Currency is USD
2.740
-0.010 (-0.36%)
Oct 27, 2025, 3:38 PM EDT
NervGen Pharma Market Cap
NervGen Pharma has a market cap or net worth of $200.36 million as of October 27, 2025. Its market cap has increased by 66.90% in one year.
Market Cap
200.36M
Enterprise Value
189.21M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.74
Market Cap Chart
Since March 15, 2019, NervGen Pharma's market cap has increased from 37.55M to 200.36M, an increase of 433.59%. That is a compound annual growth rate of 28.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 200.36M | 30.58% |
| Dec 31, 2024 | 153.43M | 25.91% |
| Dec 29, 2023 | 121.86M | 75.67% |
| Dec 30, 2022 | 69.37M | -29.11% |
| Dec 31, 2021 | 97.86M | 59.23% |
| Dec 31, 2020 | 61.46M | 38.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 806.69M |
| Elite Pharmaceuticals | 670.91M |
| Glass House Brands | 619.92M |
| Northwest Biotherapeutics | 371.21M |
| Silence Therapeutics | 344.81M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 327.16M |
| American Oncology Network | 291.52M |